US could have saved $1.5 billion on costs with drug pricing linked to benchmark, says research firm
By Sriparna Roy (Reuters) -The U.S. could have saved up to $1.5 billion in the first year following…
Eli Lilly, Sarepta, Pfizer, Medicare, Novo: Readout Newsletter
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter…